Immunocytochemistry with cytokeratin 19 and anti-Human Mesothelial Cell Antibody (HBME1) increases the diagnostic accuracy of thyroid fine-needle aspirations: Preliminary report of 150 liquid-based fine-needle aspirations with histological control

Thyroid

Volumn 21, Issue 10, 2011, Pages 1067-1073

  Cochand Priollet, Beatrix ^a   Dahan, Henri ^a   Laloi Michelin, Marie ^a   Polivka, Marc ^a   Saada, Michele ^a   Herman, Philippe ^a   Guillausseau, Pierre Jean ^a   Hamzi, Lounis ^a   Poté, Nicolas ^a   Sarfati, Emile ^b   Wassef, Michel ^a   Combe, Herve ^c   Raulic Raimond, Danielle ^d   Chedin, Pierre ^c   Medeau, Virginie ^e   Casanova, Daniele ^f   Kania, Romain ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c CENTRE HOSPITALIER VICTOR DUPOUY   (France)

^d Medical Office   (France)

^e General Hospital Center   (France)

^f Heart Center North   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN MESOTHELIAL CELL ANTIBODY 1; CELL ANTIBODY; CYTOKERATIN 19; UNCLASSIFIED DRUG;

ASPIRATION BIOPSY; ASPIRATION CYTOLOGY; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOGRAPHY; SENSITIVITY AND SPECIFICITY; THYROID CARCINOMA; THYROID NODULE;

ANTIBODIES, ANTI-IDIOTYPIC; BIOPSY, FINE-NEEDLE; CASE-CONTROL STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-19; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; THYROID GLAND; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 80053205798     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2011.0014     Document Type: Conference Paper

References (49)

1. Akerman M, Tennvall J, Biorklund A, Martensson H, Moller T 1985 Sensitivity and specificity of fine needle aspiration cytology in the diagnosis of tumors of the thyroid gland. Acta Cytol 29:850-855. (Pubitemid 16226550)
2. de Vos tot Nederveen I, Cappel RJ, Bouvy ND, Bonjer HJ, van Muiswinkel JM, Chadha S 2001 Fine needle aspiration cytology of thyroid nodules: how accurate is it and what are the causes of discrepant cases? Cytopathology 12:399-405. (Pubitemid 35300621)
3. Gharib H, Goellner JR 1993 Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med 118:282-289. (Pubitemid 23046388)
4. Ljung BM, Langer J, Mazzaferri EL, Oertel YC, Wells SA, Waisman J 2008 Training, credentialing and re-credentialing for the performance of a thyroid FNA: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol 36:400-406. (Pubitemid 351829798)
5. Mazzaferri EL 1993 Management of a solitary thyroid nodule. N Engl J Med 328:553-559. (Pubitemid 23053833)
6. Tan GH, Gharib H 1997 Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med 126: 226-231. (Pubitemid 27061578)
7. Layfield LJ, Abrams J, Cochand-Priollet B, Evans D, Gharib H, Greenspan F, Henry M, LiVolsi V, Merino M, Michael CW, Wang H, Wells SA 2008 Post-thyroid FNA testing and treatment options: a synopsis of the National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Diagn Cytopathol 36:442-448. (Pubitemid 351829802)
8. Agence Nationale Pour le Developpement de l'Evaluation Medicale 1996 Recommendations for the clinical practice. Diagnostic management of thyroid nodules. Ann Endocrinol (Paris) 57:526-535.
9. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W 2006 European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154:787-803. (Pubitemid 43997716)
10. Castro MR, Gharib H 2005 Continuing controversies in the management of thyroid nodules. Ann Intern Med 142:926-931. (Pubitemid 40791808)
11. Faquin WC 2008 The thyroid gland: recurring problems in histologic and cytologic evaluation. Arch Pathol Lab Med 132:622-632. (Pubitemid 351489616)
12. Goldstein RE, Netterville JL, Burkey B, Johnson JE 2002 Implications of follicular neoplasms, atypia, and lesions suspicious for malignancy diagnosed by fine-needle aspiration of thyroid nodules. Ann Surg 235:656-662; discussion 662-664.
13. Miller B, Burkey S, Lindberg G, Snyder WH 3rd, Nwariaku FE 2004 Prevalence of malignancy within cytologically indeterminate thyroid nodules. Am J Surg 188:459-462. (Pubitemid 39491085)
14. Kocjan G, Cochand-Priollet B, de Agustin PP, Bourgain C, Chandra A, Daneshbod Y, Deery A, Duskova J, Ersoz C, Fadda G, Fassina A, Firat P, Jimenez-Ayala B, Karakitsos P, Koperek O, Matesa N, Poller D, Ryska A, Schenck U, Sauer T, Schmitt F, Tani E, Toivonen T, Tö tsch M, Troncone G, Vass L, Vielh P 2010 Diagnostic terminology for reporting thyroid fine needle aspiration cytology: European Federation of Cytology Societies thyroid working party symposium, Lisbon 2009. Cytopathology 21:86-92.
15. The Papanicolaou Society of Cytopathology Task Force on Standards of Practice 1996 Guidelines of the Papanicolaou Society of Cytopathology for the examination of fine-needle aspiration specimens from thyroid nodules. Mod Pathol 9:710-715.
16. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Sherman SI, Tuttle RM; The American Thyroid Association Guidelines Taskforce 2006 Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:109-142.
17. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM; The American Thyroid Association Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214.
18. Gharib H, Papini E, Valcavi R, Baskin HJ, Crescenzi A, Dottorini ME, Duick DS, Guglielmi R, Hamilton CR Jr., Zeiger MA, Zini M; The AACE/AME/ETA Task Force on Thyroid Nodules 2006 American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract 12:63-102.
19. Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedü s L, Vitti P; The AACE/AME/ETA Task Force on Thyroid Nodules 2010 American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association Medical Guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract 16 Suppl 1:1-43.
20. Agarwal A, Kocjan G 2009 FNAC thyroid reporting categories: value of using the British Thyroid Association (Thy 1 to Thy 5) thyroid FNAC reporting guidelines. Cytopathology 20:133-134.
21. Baloch ZW, LiVolsi VA, Asa SL, Rosai J, Merino MJ, Randolph G, Vielh P, DeMay RM, Sidawy MK, Frable WJ 2008 Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol 36:425-437. (Pubitemid 351829800)
22. Cibas ES, Ali SZ 2009 The Bethesda system for reporting thyroid cytopathology. Thyroid 19:1159-1165.
23. Filie AC, Asa SL, Geisinger KR, Logani S, Merino M, Nikiforov YE, Clarck DP 2008 Utilization of ancillary studies in thyroid fine needle aspirates: a synopsis of the National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Diagn Cytopathol 36:438-441. (Pubitemid 351829801)
24. Kim JY, Cho H, Rhee BD, Kim HY 2002 Expression of CD44 and cyclin D1 in fine needle aspiration cytology of papillary thyroid carcinoma. Acta Cytol 46:679-683. (Pubitemid 34787427)
25. Khurana KK, Truong LD, LiVolsi VA, Baloch ZW 2003 Cytokeratin 19 immunolocalization in cell block preparation of thyroid aspirates. An adjunct to fine-needle aspiration diagnosis of papillary thyroid carcinoma. Arch Pathol Lab Med 127:579-583. (Pubitemid 36534942)
26. Papotti M, Volante M, Saggiorato E, Deandreis D, Veltri A, Orlandi F 2002 Role of galectin-3 immunodetection in the cytological diagnosis of thyroid cystic papillary carcinoma. Eur J Endocrinol 147:515-521. (Pubitemid 35238148)
27. Henry JF, Denizot A, Porcelli A, Villafane M, Zoro P, Garcia S, De Micco C 1994 Thyroperoxidase immunodetection for the diagnosis of malignancy on fine-needle aspiration of thyroid nodules. World J Surg 18:529-534. (Pubitemid 24273852)
28. Raffaelli M, De Micco C, Lubrano D, Henry JF 2001 Immunodetection of thyroid peroxidase in the diagnosis of follicular variants of thyroid papillary cancer. Ann Chir 126:148-151. (Pubitemid 32210087)
29. Barroeta JE, Baloch ZW, Lal P, Pasha TL, Zhang PJ, LiVolsi VA 2006 Diagnostic value of differential expression of CK19, Galectin-3, HBME-1, ERK, RET, and p16 in benign and malignant follicular-derived lesions of the thyroid: an immunohistochemical tissue microarray analysis. Endocr Pathol 17:225-234. (Pubitemid 46279670)
30. Sahin M, Gursoy A, Tutuncu NB, Guvener DN 2006 Prevalence and prediction of malignancy in cytologically indeterminate thyroid nodules. Clin Endocrinol (Oxf) 65:514-518. (Pubitemid 44414276)
31. Cheung YS, Poon CM, Mak SM, Suen MW, Leong HT 2007. Fine-needle aspiration cytology of thyroid nodules-how well are we doing? Hong Kong Med J 13:12-15. (Pubitemid 46482028)
32. Cochand-Priollet B, Prat JJ, Polivka M, Thienpont L, Dahan H, Wassef M, Guillausseau PJ 2003 Thyroid fine needle aspiration: the morphological features on ThinPrep slide preparations. Eighty cases with histological control. Cytopathology 14:343-349. (Pubitemid 37521866)
33. Rosai J, Kuhn E, Carcangiu ML 2006 Pitfalls in thyroid tumour pathology. Histopathology 49:107-120. (Pubitemid 44079694)
34. Choi YL, KimMK, Suh JW, Han J, Kim JH, Yang JH, NamSJ 2005 Immunoexpression of HBME-1, high molecular weight cytokeratin, cytokeratin 19, thyroid transcription factor-1, and E-cadherin in thyroid carcinomas. JKoreanMed Sci 20:853-859. (Pubitemid 41587245)
35. Nasr MR, Mukhopadhyay S, Zhang S, Katzenstein AL 2006 Immunohistochemical markers in diagnosis of papillary thyroid carcinoma: utility of HBME1 combined with CK19 immunostaining. Mod Pathol 19:1631-1637. (Pubitemid 44789932)
36. Prasad ML, Pellegata NS, Huang Y, Nagaraja HN, de la Chapelle A, Kloos RT 2005 Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors. Mod Pathol 18:48-57. (Pubitemid 40128094)
37. Asa SL 2005 The role of immunohistochemical markers in the diagnosis of follicular-patterned lesions of the thyroid. Endocr Pathol 16:295-309.
38. Nassar A, Cohen C, Siddiqui MT 2007 Utility of millipore filter and cell block in thyroid needle aspirates: which method is superior? Diagn Cytopathol 35:34-38. (Pubitemid 46095112)
39. Sanchez N, Selvaggi SM 2006 Utility of cell blocks in the diagnosis of thyroid aspirates. Diagn Cytopathol 34:89-92. (Pubitemid 43201557)
40. Fadda G, Rossi ED, Mule A, Miraglia A, Vecchio FM, Capelli A 2006 Diagnostic efficacy of immunocytochemistry on fine needle aspiration biopsies processed by thin-layer cytology. Acta Cytol 50:129-135.
41. Gong Y, Sun X, Michael CW, Attal S, Williamson BA, Bedrossian CW 2003 Immunocytochemistry of serous effusion specimens: a comparison of ThinPrep vs cell block. Diagn Cytopathol 28:1-5. (Pubitemid 36043475)
42. Cochand-Priollet B, Guillausseau PJ, Chagnon S, Hoang C, Guillausseau-Scholer C, Chanson P, Dahan H, Warnet A, Tran Ba Huy P, Valleur P 1994 The diagnostic value of fineneedle aspiration biopsy under ultrasonography in nonfunctional thyroid nodules: a prospective study comparing cytologic and histologic findings. Am J Med 97:152-157. (Pubitemid 24250675)
43. Rossi ED, Raffaelli M, Minimo C, Mule A, Lombardi CP, Vecchio FM, Fadda G 2005 Immunocytochemical evaluation of thyroid neoplasms on thin-layer smears from fine-needle aspiration biopsies. Cancer 105:87-95. (Pubitemid 40604942)
44. Nga ME, Lim GS, Soh CH, Kumarasinghe MP 2008 HBME-1 and CK19 are highly discriminatory in the cytological diagnosis of papillary thyroid carcinoma. Diagn Cytopathol 36:550-556.
45. Pazaitou-Panayiotou K, Mygdakos N, Boglou K, Kiziridou A, Chrisoulidou A, Destouni C 2010 The immunocytochemistry is a valuable tool in the diagnosis of papillary thyroid cancer in FNA's using liquid-based cytology. J Oncol 2010:963926.
46. Dujardin F, Pages JC, Collin C, de Calan L, Lecomte P, Guyetant S 2010 BRAF V600E mutation in papillary thyroid carcinoma: prevalence and detection in fine needle aspiration specimens. Ann Pathol 30:252-262.
47. Lee JH, Lee ES, Kim YS 2007 Clinicopathologic significance of BRAF V600E mutation in papillary carcinomas of the thyroid: a meta-analysis. Cancer 110:38-46.
48. Schmitt FC, Longatto-Filho A, Valent A, Vielh P 2008 Molecular techniques in cytopathology practice. J Clin Pathol 61:258-267. (Pubitemid 351354226)
49. Pizzolanti G, Russo L, Richiusa P, Bronte V, Nuara RB, Rodolico V, Amato MC, Smeraldi L, Sisto PS, Nucera M, Bommarito A, Citarrella R, Lo Coco R, Cabibi D, Lo Coco A, Frasca F, Gulotta G, Latteri MA, Modica G, Galluzzo A, Giordano C 2007 Fine-needle aspiration molecular analysis for the diagnosis of papillary thyroid carcinoma through BRAF V600E mutation and RET/PTC rearrangement. Thyroid 17:1109-1115. (Pubitemid 350207747)